Abstract
Twenty-six adults with refractory leukemia were treated with amsacrine gluconate, a new formulation. There were two complete and two partial remissions. This preparation has no apparent advantage when compared with amsacrine lactate.
MeSH terms
-
Adult
-
Aged
-
Aminoacridines / therapeutic use*
-
Amsacrine
-
Drug Evaluation
-
Female
-
Gluconates
-
Humans
-
Lactates
-
Leukemia / drug therapy*
-
Leukemia, Lymphoid / drug therapy
-
Leukemia, Myeloid / drug therapy
-
Leukemia, Myeloid, Acute / drug therapy
-
Male
-
Middle Aged
Substances
-
Aminoacridines
-
Gluconates
-
Lactates
-
Amsacrine